Login / Signup

The standard versus prolonged dual antiplatelet therapy after the XINSORB bioresorbable scaffold implantation (SPARTA) trial: study protocol for a randomized controlled trial.

Yizhe WuJiasheng YinChenguang LiWei ZhangLi ShenLei GeJuying QianJunbo Ge
Published in: Trials (2023)
ClinicalTrials.gov NCT04501900 . Registered on 6 August 2020.
Keyphrases
  • antiplatelet therapy
  • acute coronary syndrome
  • percutaneous coronary intervention
  • clinical trial
  • study protocol
  • phase iii
  • randomized controlled trial
  • coronary artery disease
  • tissue engineering